The Palmer team recently investigated whether the ALKAL2 ligand could potentiate NB progression in the absence of ALK mutation and showed that ALKAL2 overexpression in mice drives ALK TKI-sensitive NB in the absence of ALK mutation. This evidence concerns the gene ALKAL2 and neuroblastoma.